Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Jazz Pharmaceuticals

We are a pharmaceutical company focusing on improving the lives of patients through the development and commercialization of neurological and psychiatric products. We are committed to working closely with patients, patient advocacy groups and healthcare professionals.At Jazz Pharmaceuticals, we are creating innovative therapeutics by improving and expanding the uses of known compounds, and aggressively adding to our pharmaceutical product portfolio through licensing, acquisitions and collaborations.


Contact Details:
3180 Porter Drive
Palo Alto
California
94304
United States of America
Tel:(650) 496-3777
Fax:(650) 496-3781
Email:contact@jazzpharma.com
WWW:

www.jazzpharma.com/




Loading...

Recent Publications by Jazz Pharmaceuticals:

Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test.
JZP-4 is a novel with anticonvulsant, antidepressant and antimania effects...
31st March, 2009
Jazz Pharmaceuticals, Palo Alto, CA 94304, United States. Eur J Pharmacol. 2009 Jan 14;602(2-3):316-20. Epub 2008 Nov 17.
DOI Direct Link
Behavioral analyses of GHB: receptor mechanisms.
GHB is used therapeutically and recreationally, although the precise...
19th March, 2009
Clinical Research and Development, Jazz Pharmaceuticals Inc., USA. Pharmacol Ther. 2009 Jan;121(1):100-14. Epub 2008 Oct 29.
DOI Direct Link
New frontiers in the pharmacological management of Parkinson's disease.
Rasagiline, a selective COMT inhibitor, and rotigotine, a transdermal...
22nd October, 2008
Jazz Pharmaceuticals, Inc., Palo Alto, California 94304, USA. Drugs Today (Barc). 2008 Jul;44(7):531-45.
DOI Direct Link
The clinical development of gamma-hydroxybutyrate (GHB).
The discovery of gamma-hydroxybutyrate (GHB) over 40 years ago led to its...
3rd September, 2008
Orphan Medical, Inc., A subsidiary of Jazz Pharmaceuticals, Inc., Palo Curr Drug Saf. 2006 Jan;1(1):99-106.
In vivo pharmacological effects of JZP-4, a novel anticonvulsant, in models for anticonvulsant, antimania and antidepressant activity.
JZP-4 is a potent calcium and sodium channel blocker, which is currently...
7th August, 2008
Jazz Pharmaceuticals, Palo Alto, CA 94304, United States. Pharmacol Biochem Behav. 2008 Jun;89(4):523-34. Epub 2008 Feb 11.
DOI Direct Link

View more Jazz Pharmaceuticals research publications.

Press Releases on Jazz Pharmaceuticals:

BioPortfolio Logo
Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results 5th November, 2009 Jazz Pharmaceuticals, Inc.
PALO ALTO, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced financial results for the third quarter ended September 30, 2009. Total revenues for the
Jazz Pharmaceuticals to Announce Third Quarter Financial Results on November 5, 2009 29th October, 2009 Jazz Pharmaceuticals, Inc.
PALO ALTO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it will report its third quarter 2009 financial results on Thursday, November 5,
Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 11th August, 2009 Jazz Pharmaceuticals, Inc.
-- Selling, general and administrative expenses are expected to remain at about $14 million per quarter for the rest of 2009 Jazz Pharmaceuticals will host an investor conference call
Jazz Pharmaceuticals Completes $7 Million Private Placement 7th July, 2009 Jazz Pharmaceuticals, Inc.
PALO ALTO, Calif., July 7, 2009 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced the signing and closing of a private placement of an aggregate of 1,895,734 units,
Jazz Pharmaceuticals Pays Accrued Interest Under Senior Secured Notes 7th July, 2009 Jazz Pharmaceuticals, Inc.
PALO ALTO, Calif., July 7, 2009 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it has paid to the holders of its senior secured notes the interest

BioNews Results for Jazz Pharmaceuticals:

Jazz Pharmaceuticals to Present at Investor Conference
Pharma Live:  Nov 13 2009 7:06AM Matching: jazz pharmaceuticals
Jazz Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report
PR inside:  Nov 13 2009 5:22PM Matching: jazz pharmaceuticals
Jazz Pharmaceuticals to Present at Investor Conference
FinanzNachrichten.de:  Nov 11 2009 2:54AM Matching: jazz pharmaceuticals
Jazz Pharmaceuticals to Present at Investor Conference
Puget Sound Business Journal:  Nov 11 2009 8:52AM Matching: jazz pharmaceuticals
Jazz Pharmaceuticals to Present at Investor Conference
Triangle Business Journal:  Nov 11 2009 8:51AM Matching: jazz pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more Jazz Pharmaceuticals news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 419 times since April 2007, the link to the organisation's website has been followed 65 times

Recent Search Terms used to find this page: Jazz ph 650-496-3777 | jazz pharmaceuticals october 26 2009 | jazz pharmaceutical | jazz pharmaceuticals,palo alto | jazz pharmaceuticals,palo alto | jazz pharmaceuticals ghb | jazz ph | Jazz Pharmaceuticals ghb 2009 | Jazz Pharmaceuticals Research | .

Search for more companies in Palo Alto

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Jazz Pharmaceuticals

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.